Novolog/Novorapid (Insulin Aspart)

What is this medication? NOVOLOG/NOVORAPID/FIASP/TRUAPI (Insulin Aspart)Rapid Acting Insulin Brand Name US: NovologCanadian Equivalent: NovoRapid NOVOLOG/NOVORAPID/FIASP/TRUAPI (Insulin Aspart) is officially indicated for Diabetes mellitus types 1 and 2. What is a biosimilar biologic drug? Manufacturers have found cost-efficient ways to recreate the molecules used in the original or “reference” biologic drug.  Biosimilars are highly “similar” to a reference biological drug despite differing in their chemical composition.   The FDA approval of biosimilar drugs is based on a totality of evidence which is used by regulators in the approval of reference and biological drugs.  The FDA uses the same approach in evaluating biosimilars to confirm that there are no clinically meaningful differences in safety and efficacy between the reference biologic drug and the biosimilar.  The rigorous standard for authorization means that you can have confidence knowing that the quality, safety, and effica